MediXall Group, Inc.
Medixall's mission is to revolutionize the medical/healthcare industry by improving communications; providing better technology and support services; and, enabling more efficient, cost-effective healthcare for the patient.
Medixall's vision is to transform healthcare by using new systems, processes and technology to assist Providers to be more effective; to better interact with Payers, Customers and Stakeholders. Medixall believes that technology is the path to achieving our Mission.
Our Incubator will become both a research and development company, creating its own original products and formulas, and also a repository for thousands of patents created by others, who either choose to become partners, or sell their intellectual property outright. By finding the right strategic partners, we are able to add to the company an additional layer of revenue without losing focus on its own research and specialized operations.
Once the product/service is accepted into the MediXall distribution, the Revenue Model is built around Joint Venture licensing that will generate royalty revenue, and will keep expenses and overhead down.
The Incubator’s business model is highly collaborative in which the Company will engage diagnostic products/services, medical device technologies, and pharmaceutical companies in co-development, licensing, patent extension and marketing agreements. Initially, the Company’s business model will generate revenue through
- * Patenting unique processes and products to protect intellectual property
* Creating brands for marketing/manufacturing agreements with strategic partners
* Licensing technologies for royalty revenues.
MediXall Incubator is seeking to leverage its leadership team’s combined expertise in diagnostics, medical devices, pharmaceutical and proprietary healthcare to position the Company as a global leader in innovative medical technologies and services.
Key Areas that MediXall Incubator will focus on, include:
- Innovative Healthcare Solutions – Solutions that are intended to assist physicians, hospitals, and health systems, as well as government and private sector payers, to manage treatment outcomes through a patient-centered wellness principle, centered on both improving the quality of care and providing that care in a cost effective manner.
MediXaid, Inc., a Florida Corporation, is completing development of a new generation healthcare marketplace platform to address the growing need of self-pay and high deductible consumers for greater transparency in their healthcare costs. The MediXaid platform provides a B2C capability that brings together into a single cloud-based, patent-pending virtual marketplace the consumers of healthcare products and services with providers that compete on price, location and schedule for requested products and services.
The MediXaid platform will afford providers the opportunity to reach a higher percentage of self-pay and high-deductible consumers greatly benefiting the providers’ practice and assuring higher cash flow through immediate payment for services.